Literature DB >> 9679056

TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.

R Janknecht1, N J Wells, T Hunter.   

Abstract

TGF-beta and activin induce the phosphorylation and activation of Smad2 and Smad3, but how these proteins stimulate gene transcription is poorly understood. We report that TGF-beta receptor phosphorylation of Smad3 promotes its interaction with the paralogous coactivators CBP and p300, whereas CBP/p300 binding to nonphosphorylated Smad3 or its oligomerization partner Smad4 is negatively regulated by Smad-intramolecular interactions. Furthermore, p300 and TGF-beta receptor-phosphorylated Smad3 synergistically augment transcriptional activation. Thus, CBP/p300 are important components of activin/TGF-beta signaling and may mediate the antioncogenic functions of Smad2 and Smad4.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679056      PMCID: PMC317012          DOI: 10.1101/gad.12.14.2114

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

2.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Steroid receptor coactivator-1 is a histone acetyltransferase.

Authors:  T E Spencer; G Jenster; M M Burcin; C D Allis; J Zhou; C A Mizzen; N J McKenna; S A Onate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

4.  The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation.

Authors:  P H Smits; L de Wit; A J van der Eb; A Zantema
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

5.  p300 gene alterations in colorectal and gastric carcinomas.

Authors:  M Muraoka; M Konishi; R Kikuchi-Yanoshita; K Tanaka; N Shitara; J M Chong; T Iwama; M Miyaki
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

6.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

7.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.

Authors:  X Liu; Y Sun; S N Constantinescu; E Karam; R A Weinberg; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 8.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

9.  The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo.

Authors:  C Sirard; J L de la Pompa; A Elia; A Itie; C Mirtsos; A Cheung; S Hahn; A Wakeham; L Schwartz; S E Kern; J Rossant; T W Mak
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

10.  Phosphorylated CREB binds specifically to the nuclear protein CBP.

Authors:  J C Chrivia; R P Kwok; N Lamb; M Hagiwara; M R Montminy; R H Goodman
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

View more
  127 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  A function of CBP as a transcriptional co-activator during Dpp signalling.

Authors:  L Waltzer; M Bienz
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

4.  Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling.

Authors:  K Shimizu; P Y Bourillot; S J Nielsen; A M Zorn; J B Gurdon
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

6.  Smads bind directly to the Jun family of AP-1 transcription factors.

Authors:  N T Liberati; M B Datto; J P Frederick; X Shen; C Wong; E M Rougier-Chapman; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

7.  Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.

Authors:  M Fukuchi; T Imamura; T Chiba; T Ebisawa; M Kawabata; K Tanaka; K Miyazono
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

8.  Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling.

Authors:  Yili Feng; Hongxing Wu; Yongxian Xu; Zhengmao Zhang; Ting Liu; Xia Lin; Xin-Hua Feng
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.